Sessionsort ascending Date
“Utilizing Pharmacogenomics to Risk-Mitigate Chemotherapy-Related Toxicities” and “Brewing SolutionsTo the “Cold” Tumor Microenvironment: A Role for the A2A Adenosine Receptor?” 11/05/2018 - 12:00pm to 1:00pm
“Uterine Carcinosarcoma: An Evolving Paradigm for an Evolving Malignancy” and “Biosimilars: The Why, The What, The How” 03/25/2019 - 12:00pm to 1:00pm
“Understanding Cancer-Immune Interactions through Data-Driven Mathematical Modeling” 03/04/2019 - 12:00pm to 1:00pm
“Treating Young Adults with Acute Leukemia: Therapeutic Progress and Challenges” 04/22/2019 - 12:00pm to 1:00pm
“Translating the Genome in Gastroesophageal Cancer” 08/20/2018 - 12:00pm to 1:00pm
“The Role of Bacterial Driven Inflammation in TET2 Mutated Clonal Hematopoiesis: Update and Future Directions” and “Clinical and Molecular Correlates of Immunotherapy Response and Resistance” 10/22/2018 - 12:00pm to 1:00pm
“The Influence of Gut Microbiome on Response to Cancer Immunotherapy: An Ongoing Quest” and “Circulating Tumor DNA: Barriers to a Liquid Biopsy Future” 07/16/2018 - 12:00pm to 1:00pm
“The Impact of PTEN-Deficiency on Immunotherapy Response: Current Understanding and Future Directions” and “A Spotlight on the Hematologic Toxicities of Immune Checkpoint Inhibitors” 10/29/2018 - 12:00pm to 1:00pm
“The HNC Program: What it takes to Change the Standard of Care” 11/26/2018 - 12:00pm to 1:00pm
“TCR-T Cells: The Answer to Solid Tumor Immunology” and “Prognostic Implications of Driver Mutations in AML” 08/13/2018 - 12:00pm to 1:00pm